RU2011125311A - Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток - Google Patents
Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток Download PDFInfo
- Publication number
- RU2011125311A RU2011125311A RU2011125311/10A RU2011125311A RU2011125311A RU 2011125311 A RU2011125311 A RU 2011125311A RU 2011125311/10 A RU2011125311/10 A RU 2011125311/10A RU 2011125311 A RU2011125311 A RU 2011125311A RU 2011125311 A RU2011125311 A RU 2011125311A
- Authority
- RU
- Russia
- Prior art keywords
- disease
- disorder
- pathological condition
- cells
- flow cytometry
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0603—Embryonic cells ; Embryoid bodies
- C12N5/0605—Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0668—Mesenchymal stem cells from other natural sources
Abstract
1. Способ лечения индивидуума, имеющего заболевание, расстройство или патологическое состояние легких, включающий введение индивидууму терапевтически эффективного количества плацентарных стволовых клеток, причем терапевтически эффективное количество представляет собой количество, достаточное для того, чтобы вызвать детектируемое улучшение одного или нескольких симптомов указанного заболевания, расстройства или патологического состояния.2. Способ по п.1, включающий детектирование указанного улучшения с помощью одного или нескольких исследований из: спирометрии, с помощью пневмотахометра, детекции уровня СОв крови, радиографии, компьютерной томографии, магнитно-резонансной томографии, бронхоскопии или бронхоальвеолярного лаважа.3. Способ по п.1, в котором указанное заболевание, расстройство или патологическое состояние ассоциированы с иммунным ответом или вызваны им.4. Способ по п.3, в котором указанное заболевание, расстройство или патологическое состояние представляют собой аутоиммунное заболевание.5. Способ по п.4, в котором указанное аутоиммунное заболевание представляет собой ревматоидный артрит, склеродерму, воспалительную болезнь кишечника или системный волчаночный эритематоз.6. Способ по п.3, в котором указанное заболевание, расстройство или патологическое состояние представляют собой болезнь «трансплантат против хозяина».7. Способ по п.1, в котором указанное заболевание, расстройство или патологическое состояние представляют собой интерстициальную болезнь легких.8. Способ по п.7, в котором указанная интерстициальная болезнь легких представляет собой интерстициальный легочный фиброз.9. Сп�
Claims (21)
1. Способ лечения индивидуума, имеющего заболевание, расстройство или патологическое состояние легких, включающий введение индивидууму терапевтически эффективного количества плацентарных стволовых клеток, причем терапевтически эффективное количество представляет собой количество, достаточное для того, чтобы вызвать детектируемое улучшение одного или нескольких симптомов указанного заболевания, расстройства или патологического состояния.
2. Способ по п.1, включающий детектирование указанного улучшения с помощью одного или нескольких исследований из: спирометрии, с помощью пневмотахометра, детекции уровня СО2 в крови, радиографии, компьютерной томографии, магнитно-резонансной томографии, бронхоскопии или бронхоальвеолярного лаважа.
3. Способ по п.1, в котором указанное заболевание, расстройство или патологическое состояние ассоциированы с иммунным ответом или вызваны им.
4. Способ по п.3, в котором указанное заболевание, расстройство или патологическое состояние представляют собой аутоиммунное заболевание.
5. Способ по п.4, в котором указанное аутоиммунное заболевание представляет собой ревматоидный артрит, склеродерму, воспалительную болезнь кишечника или системный волчаночный эритематоз.
6. Способ по п.3, в котором указанное заболевание, расстройство или патологическое состояние представляют собой болезнь «трансплантат против хозяина».
7. Способ по п.1, в котором указанное заболевание, расстройство или патологическое состояние представляют собой интерстициальную болезнь легких.
8. Способ по п.7, в котором указанная интерстициальная болезнь легких представляет собой интерстициальный легочный фиброз.
9. Способ по п.1, в котором указанное заболевание, расстройство или патологическое состояние представляют собой обструктивную болезнь легких.
10. Способ по п.9, в котором указанной обструктивной болезнью легких является астма, бронхит, острый респираторный дистресс-синдром или хроническая обструктивная болезнь легких.
11. Способ по п.1, в котором указанным заболеванием, расстройством или патологическим состоянием является острое повреждение легких.
12. Способ по п.11, в котором указанное острое повреждение легких вызвано химическим ожогом, вдыханием дыма или воздействием токсичного вещества.
13. Способ по п.1, в котором указанным заболеванием, расстройством или патологическим состоянием является повреждение легких, вызванное неопластическим или паранеопластическим заболеванием, пневмонией или кистозным фиброзом.
14. Способ по п.13, в котором указанное введение приводит к соотношению объема форсированного выдоха за 1 с (FEV1) к форсированной жизненной емкости легких (FVC) выше 0,7.
15. Способ по п.1, в котором указанные плацентарные стволовые клетки имеют характеристики: CD10+, CD34-, CD105+, определяемые с помощью проточной цитометрии.
16. Способ по п.15, в котором указанные клетки имеют характеристику CD200+, определяемую с помощью проточной цитометрии.
17. Способ по п.16, в котором указанные клетки имеют характеристики: CD90+ и CD45-, определяемые с помощью проточной цитометрии.
18. Способ по п.17, в котором указанные клетки имеют характеристику CD44+, определяемую с помощью проточной цитометрии.
19. Способ по п.17, в котором указанные клетки имеют характеристики: CD80- и CD86-, определяемые с помощью проточной цитометрии.
20. Способ по п.15, в котором указанные клетки имеют одну или несколько из следующих характеристик: CD29+, CD38-, CD44+, CD54+, SH3+ или SH4+, определяемых с помощью проточной цитометрии.
21. Способ по п.15, в котором указанные клетки имеют одну или несколько из следующих характеристик: CD200+, CD44+, CD45-, CD90+, CD117-, CD133-, KDR-, CD80-, CD86-, HLA-ABC+, HLA-DR- или PDL+.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11700408P | 2008-11-21 | 2008-11-21 | |
US61/117,004 | 2008-11-21 | ||
PCT/US2009/065509 WO2010060031A1 (en) | 2008-11-21 | 2009-11-23 | Treatment of diseases, disorders or conditions of the lung using placental cells |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2015143254A Division RU2732240C2 (ru) | 2008-11-21 | 2009-11-23 | Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011125311A true RU2011125311A (ru) | 2012-12-27 |
RU2570550C2 RU2570550C2 (ru) | 2015-12-10 |
Family
ID=42198531
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011125311/10A RU2570550C2 (ru) | 2008-11-21 | 2009-11-23 | Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток |
RU2015143254A RU2732240C2 (ru) | 2008-11-21 | 2009-11-23 | Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2015143254A RU2732240C2 (ru) | 2008-11-21 | 2009-11-23 | Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток |
Country Status (12)
Country | Link |
---|---|
US (1) | US20100143312A1 (ru) |
EP (1) | EP2375907B1 (ru) |
AU (1) | AU2009316376B2 (ru) |
BR (1) | BRPI0921999B8 (ru) |
CA (1) | CA2743573C (ru) |
DK (1) | DK2375907T3 (ru) |
ES (1) | ES2731340T3 (ru) |
IL (2) | IL212958B (ru) |
MX (1) | MX2011005230A (ru) |
NZ (2) | NZ592839A (ru) |
RU (2) | RU2570550C2 (ru) |
WO (1) | WO2010060031A1 (ru) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4294316B2 (ja) | 2000-12-06 | 2009-07-08 | ハリリ,ロバート,ジェイ. | 胎盤幹細胞の回収方法 |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
IL157392A0 (en) | 2001-02-14 | 2004-02-19 | Robert J Hariri | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
US7700090B2 (en) | 2002-02-13 | 2010-04-20 | Anthrogenesis Corporation | Co-culture of placental stem cells and stem cells from a second source |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
KR20050086780A (ko) * | 2002-11-26 | 2005-08-30 | 안트로제네시스 코포레이션 | 세포요법제, 세포요법제 단위 및 이를 이용한 치료방법 |
WO2005097190A2 (en) * | 2004-03-26 | 2005-10-20 | Celgene Corporation | Systems and methods for providing a stem cell bank |
KR20080056302A (ko) * | 2005-10-13 | 2008-06-20 | 안트로제네시스 코포레이션 | 태반 유래 줄기세포로부터 생산된 희소돌기 아교세포 |
SI1957633T1 (sl) | 2005-10-13 | 2014-04-30 | Anthrogenesis Corporation | Imunomodulacija z uporabo matičnih celic iz placente |
WO2007079185A2 (en) * | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Improved composition for collecting and preserving placental stem cells and methods of using the composition |
KR20180105266A (ko) | 2005-12-29 | 2018-09-27 | 안트로제네시스 코포레이션 | 태반 줄기 세포 집단 |
US7993918B2 (en) * | 2006-08-04 | 2011-08-09 | Anthrogenesis Corporation | Tumor suppression using placental stem cells |
EP3483263A1 (en) | 2006-10-23 | 2019-05-15 | Celularity, Inc. | Methods and compositions for treatment of bone defects with placental cell populations |
WO2008100497A1 (en) | 2007-02-12 | 2008-08-21 | Anthrogenesis Corporation | Hepatocytes and chondrocytes from adherent placental stem cells; and cd34+, cd45- placental stem cell-enriched cell populations |
PT2120977E (pt) | 2007-02-12 | 2013-09-16 | Anthrogenesis Corp | Tratamento de doenças inflamatórias utilizando células estaminais da placenta |
US9200253B1 (en) | 2007-08-06 | 2015-12-01 | Anthrogenesis Corporation | Method of producing erythrocytes |
KR20150088336A (ko) | 2007-09-28 | 2015-07-31 | 안트로제네시스 코포레이션 | 인간 태반 관류액 및 인간 태반-유래 중간체 천연 킬러 세포를 사용한 종양 억제 방법 |
KR20180049231A (ko) | 2008-08-20 | 2018-05-10 | 안트로제네시스 코포레이션 | 개선된 세포 조성물 및 그의 제조 방법 |
MX339068B (es) | 2008-08-22 | 2016-05-10 | Anthrogenesis Corp | Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias. |
CA2735790C (en) | 2008-09-02 | 2017-02-28 | Pluristem Ltd. | Adherent cells from placenta tissue and use thereof in therapy |
WO2010071864A1 (en) * | 2008-12-19 | 2010-06-24 | Ethicon, Incorporated | Treatment of lung and pulmonary diseases and disorders |
US20130302283A1 (en) * | 2012-05-14 | 2013-11-14 | Advanced Technologies And Regenerative Medicine, Llc | hUTC MODULATION OF PRO-INFLAMMATORY MEDIATORS OF LUNG AND PULMONARY DISEASES AND DISORDERS |
US8586360B2 (en) | 2009-07-02 | 2013-11-19 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
DK3284818T3 (da) | 2010-01-26 | 2022-06-20 | Celularity Inc | Behandling af knoglerelateret kræft ved hjælp af placenta stamceller |
TWI756797B (zh) | 2010-04-07 | 2022-03-01 | 美商瑟魯勒瑞堤股份有限公司 | 利用胎盤幹細胞之血管新生 |
CN102933221A (zh) * | 2010-04-08 | 2013-02-13 | 人类起源公司 | 使用胎盘干细胞治疗结节病 |
US8883210B1 (en) | 2010-05-14 | 2014-11-11 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US10130736B1 (en) | 2010-05-14 | 2018-11-20 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
US9352003B1 (en) | 2010-05-14 | 2016-05-31 | Musculoskeletal Transplant Foundation | Tissue-derived tissuegenic implants, and methods of fabricating and using same |
CN101856496B (zh) * | 2010-06-07 | 2013-09-18 | 四川大学 | 胎盘干细胞抗肿瘤疫苗及其制备方法与应用 |
KR20220053695A (ko) | 2010-07-13 | 2022-04-29 | 셀룰래리티 인코포레이티드 | 천연 킬러 세포의 생성 방법 |
WO2012092485A1 (en) | 2010-12-31 | 2012-07-05 | Anthrogenesis Corporation | Enhancement of placental stem cell potency using modulatory rna molecules |
KR20140107103A (ko) | 2011-02-14 | 2014-09-04 | 미메딕스 그룹 인크. | 마이크로화된 태반 조직 조성물 및 이의 제조 및 사용 방법 |
US20140205646A1 (en) | 2011-02-14 | 2014-07-24 | Mimedx Group, Inc. | Tissue grafts modified with a cross-linking agent and method of making and using the same |
WO2012127320A1 (en) | 2011-03-22 | 2012-09-27 | Pluristem Ltd. | Methods for treating radiation or chemical injury |
DK2714059T3 (en) | 2011-06-01 | 2019-01-21 | Celularity Inc | TREATMENT OF PAIN WHEN USING PLACENT STAM CELLS |
EP2731440A4 (en) * | 2011-07-15 | 2015-04-29 | Anthrogenesis Corp | RADIATION LESSON TREATMENT USING ADHESENT CELLS DERIVED FROM AMNIOS |
WO2013055476A1 (en) | 2011-09-09 | 2013-04-18 | Anthrogenesis Corporation | Treatment of amyotrophic lateral sclerosis using placental stem cells |
EP2793745B1 (en) | 2011-12-22 | 2019-07-31 | MIMEDX Group Inc. | Cross-linked dehydrated placental tissue grafts and methods for making and using the same |
EP2798058B1 (en) * | 2011-12-30 | 2017-10-18 | Amit Patel | Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses |
US11338063B2 (en) | 2012-08-15 | 2022-05-24 | Mimedx Group, Inc. | Placental tissue grafts modified with a cross-linking agent and methods of making and using the same |
WO2014028657A1 (en) | 2012-08-15 | 2014-02-20 | Mimedx Group, Inc | Reinforced placental tissue grafts and methods of making and using the same |
US8904664B2 (en) | 2012-08-15 | 2014-12-09 | Mimedx Group, Inc. | Dehydration device and methods for drying biological materials |
US9943551B2 (en) | 2012-08-15 | 2018-04-17 | Mimedx Group, Inc. | Tissue grafts composed of micronized placental tissue and methods of making and using the same |
US9180145B2 (en) | 2012-10-12 | 2015-11-10 | Mimedx Group, Inc. | Compositions and methods for recruiting and localizing stem cells |
US9155799B2 (en) | 2012-11-19 | 2015-10-13 | Mimedx Group, Inc. | Cross-linked collagen with at least one bound antimicrobial agent for in vivo release of the agent |
US8946163B2 (en) | 2012-11-19 | 2015-02-03 | Mimedx Group, Inc. | Cross-linked collagen comprising metallic anticancer agents |
US10517931B2 (en) | 2013-01-17 | 2019-12-31 | Mimedx Group, Inc. | Non-surgical, localized delivery of compositions for placental growth factors |
US9655948B1 (en) | 2013-01-17 | 2017-05-23 | Mimedx Group, Inc. | Non-surgical, localized delivery of compositions for placental growth factors |
US9827293B2 (en) | 2013-01-17 | 2017-11-28 | Mimedx Group, Inc. | Non-surgical, localized delivery of compositions for placental growth factors |
US10206977B1 (en) | 2013-01-18 | 2019-02-19 | Mimedx Group, Inc. | Isolated placental stem cell recruiting factors |
WO2014113733A1 (en) | 2013-01-18 | 2014-07-24 | Mimedx Group, Inc. | Methods for treating cardiac conditions |
WO2014123879A1 (en) | 2013-02-05 | 2014-08-14 | Anthrogenesis Corporation | Natural killer cells from placenta |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
US10029030B2 (en) | 2013-03-15 | 2018-07-24 | Mimedx Group, Inc. | Molded placental tissue compositions and methods of making and using the same |
US9446142B2 (en) | 2013-05-28 | 2016-09-20 | Mimedx Group, Inc. | Polymer chelator conjugates |
CN105916521A (zh) | 2013-11-15 | 2016-08-31 | 人类起源公司 | 包含人胎盘灌注液细胞、其亚群的组合物及其用途 |
US20170042944A1 (en) * | 2014-04-21 | 2017-02-16 | Anthrogenesis Corporation | Treatment of conditions and complications in infants |
EP3185918B1 (en) | 2014-08-28 | 2021-08-18 | MiMedx Group, Inc. | Collagen reinforced tissue grafts |
WO2016044421A1 (en) * | 2014-09-18 | 2016-03-24 | National Health Research Institutes | Progenitor cells, method for preparation thereof and uses thereof |
WO2016073768A1 (en) | 2014-11-05 | 2016-05-12 | Veracyte, Inc. | Systems and methods of diagnosing idiopathic pulmonary fibrosis on transbronchial biopsies using machine learning and high dimensional transcriptional data |
WO2016086020A1 (en) * | 2014-11-24 | 2016-06-02 | Cytostormrx Llc | Encapsulated stem cells for the treatment of inflammatory disease |
US10342830B2 (en) * | 2015-01-05 | 2019-07-09 | Gary M. Petrucci | Methods and materials for treating lung disorders |
WO2016111900A1 (en) * | 2015-01-05 | 2016-07-14 | Petrucci Gary M | Methods and materials for treating arthritis |
CA2986702C (en) | 2015-05-21 | 2023-04-04 | David Wang | Modified demineralized cortical bone fibers |
ES2914692T3 (es) | 2015-08-12 | 2022-06-15 | Cha Biotech Co Ltd | Células madre adhesivas derivadas de cordón umbilical mejoradas, método de preparación para las mismas, y uso de las mismas |
US10993969B2 (en) | 2016-02-05 | 2021-05-04 | Gary M. Petrucci | Methods and materials for treating nerve injuries and neurological disorders |
WO2018185584A1 (en) * | 2017-04-05 | 2018-10-11 | Pluristem Ltd. | Methods and compositions for treating acute lung injury and respiratory distress syndrome |
US10478531B2 (en) | 2017-06-22 | 2019-11-19 | Gary M. Petrucci | Methods and materials for treating blood vessels |
US10251917B1 (en) | 2017-09-19 | 2019-04-09 | Gary M. Petrucci | Methods and materials for treating tumors |
WO2019239295A1 (en) * | 2018-06-11 | 2019-12-19 | Pluristem Ltd. | Therapeutic dosage regimens comprising adherent stromal cells |
WO2021183774A1 (en) * | 2020-03-12 | 2021-09-16 | Angion Biomedica Corp. | Treating acute respiratory distress |
IL281447A (en) * | 2020-03-12 | 2021-09-30 | Pluristem Ltd | Methods and compounds for the treatment of viral infections |
WO2021195438A1 (en) * | 2020-03-25 | 2021-09-30 | Predictive Technology Group, Inc. | Treatment of respiratory damage |
WO2021226602A1 (en) * | 2020-05-08 | 2021-11-11 | Celularity Inc. | Placenta-derived adherent (pda) stem cell for the treatment of adults with sars-cov-2 related acute respiratory failure and ards (covid-19) |
RU2746833C1 (ru) * | 2020-08-03 | 2021-04-21 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ | Способ моделирования экспериментального воспаления легких у крыс |
Family Cites Families (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3862002A (en) * | 1962-05-08 | 1975-01-21 | Sanfar Lab Inc | Production of physiologically active placental substances |
US4798824A (en) | 1985-10-03 | 1989-01-17 | Wisconsin Alumni Research Foundation | Perfusate for the preservation of organs |
US5863531A (en) * | 1986-04-18 | 1999-01-26 | Advanced Tissue Sciences, Inc. | In vitro preparation of tubular tissue structures by stromal cell culture on a three-dimensional framework |
US5004681B1 (en) * | 1987-11-12 | 2000-04-11 | Biocyte Corp | Preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood |
US5192553A (en) * | 1987-11-12 | 1993-03-09 | Biocyte Corporation | Isolation and preservation of fetal and neonatal hematopoietic stem and progenitor cells of the blood and methods of therapeutic use |
US5284766A (en) * | 1989-02-10 | 1994-02-08 | Kao Corporation | Bed material for cell culture |
US5605822A (en) * | 1989-06-15 | 1997-02-25 | The Regents Of The University Of Michigan | Methods, compositions and devices for growing human hematopoietic cells |
US5464764A (en) * | 1989-08-22 | 1995-11-07 | University Of Utah Research Foundation | Positive-negative selection methods and vectors |
US5061620A (en) * | 1990-03-30 | 1991-10-29 | Systemix, Inc. | Human hematopoietic stem cell |
US5197985A (en) * | 1990-11-16 | 1993-03-30 | Caplan Arnold I | Method for enhancing the implantation and differentiation of marrow-derived mesenchymal cells |
US6010696A (en) * | 1990-11-16 | 2000-01-04 | Osiris Therapeutics, Inc. | Enhancing hematopoietic progenitor cell engraftment using mesenchymal stem cells |
US5733542A (en) * | 1990-11-16 | 1998-03-31 | Haynesworth; Stephen E. | Enhancing bone marrow engraftment using MSCS |
US5190556A (en) | 1991-03-19 | 1993-03-02 | O.B. Tech, Inc. | Cord cutter sampler |
US5744361A (en) * | 1991-04-09 | 1998-04-28 | Indiana University | Expansion of human hematopoietic progenitor cells in a liquid medium |
US5552267A (en) | 1992-04-03 | 1996-09-03 | The Trustees Of Columbia University In The City Of New York | Solution for prolonged organ preservation |
AU5152293A (en) * | 1992-10-08 | 1994-05-09 | Kennedy Institute Of Rheumatology, The | Treatment of autoimmune and inflammatory disorders |
UA40613C2 (ru) * | 1993-03-31 | 2001-08-15 | Про-Нейрон, Інк. | Полипептид, имеющий активность ингибитора пролиферации стволовых клеток (варианты), фармацевтическая композиция (варианты), фармацевтическая композиция для ингибирования деления стволовых клеток у млекопитающих, фармацевтическая композиция для лечения заболеваний, которые включают гиперпролиферативные состояния, фармацевтическая композиция для дифференциальной защиты нормальных стволовых клеток, отличающихся от лейкозных, способ очистки полипептида |
US5709854A (en) * | 1993-04-30 | 1998-01-20 | Massachusetts Institute Of Technology | Tissue formation by injecting a cell-polymeric solution that gels in vivo |
US5372581A (en) | 1993-07-21 | 1994-12-13 | Minneapolis Children's Services Corporation | Method and apparatus for placental blood collection |
US5591625A (en) * | 1993-11-24 | 1997-01-07 | Case Western Reserve University | Transduced mesenchymal stem cells |
US6288030B1 (en) * | 1993-12-22 | 2001-09-11 | Amgen Inc. | Stem cell factor formulations and methods |
RU2245365C2 (ru) * | 1994-01-03 | 2005-01-27 | Генентек Инк. | Тромбопоэтин |
AU686823B2 (en) * | 1994-06-06 | 1998-02-12 | Case Western Reserve University | Biomatrix for tissue regeneration |
US6174333B1 (en) * | 1994-06-06 | 2001-01-16 | Osiris Therapeutics, Inc. | Biomatrix for soft tissue regeneration using mesenchymal stem cells |
US6103522A (en) * | 1994-07-20 | 2000-08-15 | Fred Hutchinson Cancer Research Center | Human marrow stromal cell lines which sustain hematopoiesis |
US5874301A (en) * | 1994-11-21 | 1999-02-23 | National Jewish Center For Immunology And Respiratory Medicine | Embryonic cell populations and methods to isolate such populations |
US5736396A (en) * | 1995-01-24 | 1998-04-07 | Case Western Reserve University | Lineage-directed induction of human mesenchymal stem cell differentiation |
US5695998A (en) * | 1995-02-10 | 1997-12-09 | Purdue Research Foundation | Submucosa as a growth substrate for islet cells |
US6011000A (en) * | 1995-03-03 | 2000-01-04 | Perrine; Susan P. | Compositions for the treatment of blood disorders |
US5906934A (en) * | 1995-03-14 | 1999-05-25 | Morphogen Pharmaceuticals, Inc. | Mesenchymal stem cells for cartilage repair |
US5716616A (en) * | 1995-03-28 | 1998-02-10 | Thomas Jefferson University | Isolated stromal cells for treating diseases, disorders or conditions characterized by bone defects |
US5733541A (en) * | 1995-04-21 | 1998-03-31 | The Regent Of The University Of Michigan | Hematopoietic cells: compositions and methods |
US5925567A (en) * | 1995-05-19 | 1999-07-20 | T. Breeders, Inc. | Selective expansion of target cell populations |
US5877299A (en) * | 1995-06-16 | 1999-03-02 | Stemcell Technologies Inc. | Methods for preparing enriched human hematopoietic cell preparations |
US5858782A (en) * | 1995-11-13 | 1999-01-12 | Regents Of The University Of Michigan | Functional human hematopoietic cells |
ATE319827T1 (de) * | 1995-11-17 | 2006-03-15 | Asahi Chemical Ind | Polypeptid, das die differenzierung unterdrueckt |
US5716794A (en) * | 1996-03-29 | 1998-02-10 | Xybernaut Corporation | Celiac antigen |
CA2251983C (en) * | 1996-04-19 | 2003-12-16 | Sudhakar Kadiyala | Regeneration and augmentation of bone using mesenchymal stem cells |
US5919176A (en) * | 1996-05-14 | 1999-07-06 | Children's Hospital Medical Center Of Northern California | Apparatus and method for collecting blood from an umbilical cord |
US5827740A (en) * | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
US5916202A (en) * | 1996-08-30 | 1999-06-29 | Haswell; John N. | Umbilical cord blood collection |
US6335195B1 (en) * | 1997-01-28 | 2002-01-01 | Maret Corporation | Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation |
US5879318A (en) * | 1997-08-18 | 1999-03-09 | Npbi International B.V. | Method of and closed system for collecting and processing umbilical cord blood |
AU9127098A (en) * | 1997-09-04 | 1999-03-22 | Osiris Therapeutics, Inc. | Ligands that modulate differentiation of mesenchymal stem cells |
EP1062321B1 (en) * | 1998-03-13 | 2004-12-29 | Osiris Therapeutics, Inc. | Uses for humane non-autologous mesenchymal stem cells |
US6368636B1 (en) * | 1998-03-18 | 2002-04-09 | Osiris Therapeutics, Inc. | Mesenchymal stem cells for prevention and treatment of immune responses in transplantation |
EP1108011A2 (en) * | 1998-06-08 | 2001-06-20 | Osiris Therapeutics, Inc. | In vitro maintenance of hematopoietic stem cells |
US7157418B1 (en) * | 1998-07-22 | 2007-01-02 | Osprey Pharmaceuticals, Ltd. | Methods and compositions for treating secondary tissue damage and other inflammatory conditions and disorders |
CA2338712C (en) * | 1998-07-28 | 2012-10-09 | Synergen Ag | Use of creatine compounds for treatment of bone or cartilage cells and tissues |
US6548299B1 (en) * | 1999-11-12 | 2003-04-15 | Mark J. Pykett | Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices |
US6184035B1 (en) * | 1998-11-18 | 2001-02-06 | California Institute Of Technology | Methods for isolation and activation of, and control of differentiation from, skeletal muscle stem or progenitor cells |
US20020006901A1 (en) * | 1999-02-05 | 2002-01-17 | Aldo T. Iacono | Use of aerosolized cyclosporine for prevention and treatment of pulmonary disease |
US20030007954A1 (en) * | 1999-04-12 | 2003-01-09 | Gail K. Naughton | Methods for using a three-dimensional stromal tissue to promote angiogenesis |
US6333029B1 (en) * | 1999-06-30 | 2001-12-25 | Ethicon, Inc. | Porous tissue scaffoldings for the repair of regeneration of tissue |
US8075881B2 (en) * | 1999-08-05 | 2011-12-13 | Regents Of The University Of Minnesota | Use of multipotent adult stem cells in treatment of myocardial infarction and congestive heart failure |
US6685936B2 (en) * | 1999-10-12 | 2004-02-03 | Osiris Therapeutics, Inc. | Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation |
US7311905B2 (en) * | 2002-02-13 | 2007-12-25 | Anthrogenesis Corporation | Embryonic-like stem cells derived from post-partum mammalian placenta, and uses and methods of treatment using said cells |
JP4294316B2 (ja) * | 2000-12-06 | 2009-07-08 | ハリリ,ロバート,ジェイ. | 胎盤幹細胞の回収方法 |
US20080152629A1 (en) * | 2000-12-06 | 2008-06-26 | James Edinger | Placental stem cell populations |
US20030045552A1 (en) * | 2000-12-27 | 2003-03-06 | Robarge Michael J. | Isoindole-imide compounds, compositions, and uses thereof |
IL157392A0 (en) * | 2001-02-14 | 2004-02-19 | Robert J Hariri | Renovation and repopulation of decellularized tissues and cadaveric organs by stem cells |
EP2336299A1 (en) * | 2001-02-14 | 2011-06-22 | Anthrogenesis Corporation | Post-partum mammalian placenta, its use and placental stem cells therefrom |
US20030044977A1 (en) * | 2001-08-10 | 2003-03-06 | Norio Sakuragawa | Human stem cells originated from human amniotic mesenchymal cell layer |
WO2003061591A2 (en) * | 2002-01-22 | 2003-07-31 | Advanced Cell Technology, Inc. | Stem cell-derived endothelial cells modified to disrupt tumor angiogenesis |
US20030187515A1 (en) * | 2002-03-26 | 2003-10-02 | Hariri Robert J. | Collagen biofabric and methods of preparing and using the collagen biofabric |
US7498171B2 (en) * | 2002-04-12 | 2009-03-03 | Anthrogenesis Corporation | Modulation of stem and progenitor cell differentiation, assays, and uses thereof |
AU2003231950A1 (en) * | 2002-05-30 | 2003-12-19 | Celgene Corporation | Modulating cell differentiation and treating myeloproliferative disorders with JNK/MKK inhibitors |
US7422736B2 (en) * | 2002-07-26 | 2008-09-09 | Food Industry Research And Development Institute | Somatic pluripotent cells |
KR20050105467A (ko) * | 2003-02-13 | 2005-11-04 | 안트로제네시스 코포레이션 | 질병, 장애 또는 증상을 보유하는 개체의 치료에 있어서제대혈의 용도 |
PL1641918T3 (pl) * | 2003-06-27 | 2016-06-30 | Depuy Synthes Products Inc | Komórki poporodowe do zastosowania w leczeniu choroby serca i układu krążenia |
US7569385B2 (en) * | 2003-08-14 | 2009-08-04 | The Regents Of The University Of California | Multipotent amniotic fetal stem cells |
US20050131028A1 (en) * | 2003-09-11 | 2005-06-16 | Pharmacia Corporation | Methods and compositions for the extended duration treatment of pain, inflammation and inflammation-related disorders |
US20050089513A1 (en) * | 2003-10-28 | 2005-04-28 | Norio Sakuragawa | Side population cells originated from human amnion and their uses |
US7147626B2 (en) * | 2004-09-23 | 2006-12-12 | Celgene Corporation | Cord blood and placenta collection kit |
US7909806B2 (en) * | 2004-09-23 | 2011-03-22 | Anthrogenesis Corporation | Cord blood and placenta collection kit |
WO2006074308A2 (en) * | 2005-01-07 | 2006-07-13 | Wake Forest University Health Sciences | Regeneration of pancreatic islets by amniotic fluid stem cell therapy |
US7642091B2 (en) * | 2005-02-24 | 2010-01-05 | Jau-Nan Lee | Human trophoblast stem cells and use thereof |
AU2006257878A1 (en) * | 2005-06-10 | 2006-12-21 | Celgene Corporation | Human placental collagen compositions, processes for their preparation, methods of their use and kits comprising the compositions |
BRPI0612121A2 (pt) * | 2005-06-30 | 2016-09-06 | Anthrogenesis Corp | método de reparo de uma membrana timpânica que tenha uma deformidade, e, biotecido de colágeno |
WO2007009061A2 (en) * | 2005-07-13 | 2007-01-18 | Anthrogenesis Corporation | Ocular plug formed from placenta derived collagen biofabric |
US7928280B2 (en) * | 2005-07-13 | 2011-04-19 | Anthrogenesis Corporation | Treatment of leg ulcers using placenta derived collagen biofabric |
WO2007011693A2 (en) * | 2005-07-14 | 2007-01-25 | Medistem Laboratories, Inc. | Compositions of placentally-derived stem cells for the treatment of cancer |
SI1957633T1 (sl) * | 2005-10-13 | 2014-04-30 | Anthrogenesis Corporation | Imunomodulacija z uporabo matičnih celic iz placente |
WO2007079185A2 (en) | 2005-12-29 | 2007-07-12 | Anthrogenesis Corporation | Improved composition for collecting and preserving placental stem cells and methods of using the composition |
KR20180105266A (ko) * | 2005-12-29 | 2018-09-27 | 안트로제네시스 코포레이션 | 태반 줄기 세포 집단 |
WO2007146123A2 (en) * | 2006-06-09 | 2007-12-21 | Anthrogenesis Corporation | Placental niche and use thereof to culture stem cells |
US8105634B2 (en) * | 2006-08-15 | 2012-01-31 | Anthrogenesis Corporation | Umbilical cord biomaterial for medical use |
PT2120977E (pt) * | 2007-02-12 | 2013-09-16 | Anthrogenesis Corp | Tratamento de doenças inflamatórias utilizando células estaminais da placenta |
WO2008144820A1 (en) * | 2007-05-28 | 2008-12-04 | Monash University | Treatment of chronic lung disease |
EP2014767A1 (en) * | 2007-06-15 | 2009-01-14 | Centro di Ricerca E. Menni | T cell immunomodulation by placenta cell preparations |
KR20180049231A (ko) * | 2008-08-20 | 2018-05-10 | 안트로제네시스 코포레이션 | 개선된 세포 조성물 및 그의 제조 방법 |
KR20200143506A (ko) * | 2008-08-20 | 2020-12-23 | 안트로제네시스 코포레이션 | 단리된 태반 세포를 사용한 뇌졸중 치료 |
MX339068B (es) * | 2008-08-22 | 2016-05-10 | Anthrogenesis Corp | Metodos y composiciones para el tratamiento de defectos oseos con poblaciones de celulas placentarias. |
US8586360B2 (en) * | 2009-07-02 | 2013-11-19 | Anthrogenesis Corporation | Method of producing erythrocytes without feeder cells |
-
2009
- 2009-11-23 WO PCT/US2009/065509 patent/WO2010060031A1/en active Application Filing
- 2009-11-23 CA CA2743573A patent/CA2743573C/en active Active
- 2009-11-23 NZ NZ592839A patent/NZ592839A/xx unknown
- 2009-11-23 AU AU2009316376A patent/AU2009316376B2/en active Active
- 2009-11-23 MX MX2011005230A patent/MX2011005230A/es active IP Right Grant
- 2009-11-23 ES ES09828342T patent/ES2731340T3/es active Active
- 2009-11-23 US US12/624,359 patent/US20100143312A1/en not_active Abandoned
- 2009-11-23 DK DK09828342.7T patent/DK2375907T3/da active
- 2009-11-23 NZ NZ602569A patent/NZ602569A/en unknown
- 2009-11-23 EP EP09828342.7A patent/EP2375907B1/en active Active
- 2009-11-23 RU RU2011125311/10A patent/RU2570550C2/ru active
- 2009-11-23 RU RU2015143254A patent/RU2732240C2/ru active
- 2009-11-23 BR BRPI0921999A patent/BRPI0921999B8/pt active IP Right Grant
-
2011
- 2011-05-17 IL IL212958A patent/IL212958B/en active IP Right Grant
-
2018
- 2018-06-18 IL IL260117A patent/IL260117A/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP2375907A1 (en) | 2011-10-19 |
DK2375907T3 (da) | 2019-06-11 |
CA2743573A1 (en) | 2010-05-27 |
AU2009316376A1 (en) | 2010-05-27 |
ES2731340T3 (es) | 2019-11-15 |
EP2375907B1 (en) | 2019-02-27 |
EP2375907A4 (en) | 2014-11-05 |
WO2010060031A1 (en) | 2010-05-27 |
RU2732240C2 (ru) | 2020-09-14 |
IL212958B (en) | 2018-07-31 |
RU2015143254A (ru) | 2018-12-28 |
MX2011005230A (es) | 2011-06-16 |
NZ602569A (en) | 2014-03-28 |
BRPI0921999B1 (pt) | 2021-04-06 |
RU2015143254A3 (ru) | 2019-06-06 |
US20100143312A1 (en) | 2010-06-10 |
BRPI0921999A2 (pt) | 2018-12-26 |
CA2743573C (en) | 2021-04-27 |
IL260117A (en) | 2018-07-31 |
AU2009316376B2 (en) | 2015-08-20 |
RU2570550C2 (ru) | 2015-12-10 |
BRPI0921999B8 (pt) | 2021-05-25 |
IL212958A0 (en) | 2011-07-31 |
NZ592839A (en) | 2012-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2011125311A (ru) | Лечение заболеваний, расстройств или патологических состояний легких с использованием плацентарных клеток | |
Yang et al. | Dysbiosis of the salivary microbiome is associated with non-smoking female lung cancer and correlated with immunocytochemistry markers | |
Lu et al. | The microRNA miR-22 inhibits the histone deacetylase HDAC4 to promote TH17 cell–dependent emphysema | |
Mathioudakis et al. | Impact of long‐term treatment with low‐dose inhaled corticosteroids on the bone mineral density of chronic obstructive pulmonary disease patients: aggravating or beneficial? | |
Parker et al. | Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study | |
Fayon et al. | Clinimetric properties of bronchoalveolar lavage inflammatory markers in cystic fibrosis | |
Ito et al. | Nasal mucociliary clearance in subjects with COPD after smoking cessation | |
Tsao et al. | Protection against Klebsiella pneumoniae using lithium chloride in an intragastric infection model | |
O'Reilly et al. | Using cell-based strategies to break the link between bronchopulmonary dysplasia and the development of chronic lung disease in later life | |
Brodlie et al. | Can cells other than Th17 lymphocytes be important sources of IL-17 in the lungs? | |
Foster et al. | Deficiency in the zinc transporter ZIP8 impairs epithelia renewal and enhances lung fibrosis | |
Khairsyaf et al. | Long Covid Incidence and Influencing Factors of Covid-19 Survivors in the Working Area of Lubuk Begalung Health Center, Padang | |
Bikov et al. | Methodological issues and possible clinical implications for exhaled breath condensate pH in asthma | |
Chu et al. | Case of interstitial lung disease possibly induced by exposure to iron dust | |
Goeckenjan | Respiratory bronchiolitis-associated interstitial lung disease (RB-ILD) | |
Asri et al. | Exposure of aflatoxin B1 (AFB1) in inhalable dust and its respiratory effects among rice millers | |
Gupta et al. | Prevalence of cardiovascular diseases in patients hospitalized for acute exacerbation of COPD: prospective observational study | |
Lange et al. | The Copenhagen City Heart Study Experience and its Key Contributions to Chronic Obstructive Pulmonary Disease | |
Kralimarkova et al. | Exhaled breath temperature and tobacco smoking | |
Mastalerz et al. | Altered metabolism of prostaglandin $ E_ {2} $ in asthma patients with aspirin hypersensitivity | |
RU2008141218A (ru) | Способ дифференциальной диагностики инфильтративного туберкулеза и периферического рака легких | |
Säynäjäkangas et al. | A bronchiectatic patient's risk of pneumonia and prognosis | |
Lee | Recurrent giant cell interstitial pneumonia: case report | |
Girish et al. | A Cross-sectional study on effect of Covid 19 infection among smokers in Chamarajanagar district. | |
Molyneaux et al. | A94 TOMORROW NEVER KNOWS: IDIOPATHIC PULMONARY FIBROSIS TRANSLATIONAL PATHOBIOLOGY: The Longitudinal Peripheral Whole Blood Transcriptome In Idiopathic Pulmonary Fibrosis |